Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants | Zendy

Shabih U. Hasan | Zendy; Jim Potenziano | Zendy; Girija G. Konduri | Zendy; José A. Pérez | Zendy; Krisa P. Van Meurs | Zendy; M. Whit Walker | Zendy; Bradley A. Yoder | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants

Author(s) -

Shabih U. Hasan,

Jim Potenziano,

Girija G. Konduri,

José A. Pérez,

Krisa P. Van Meurs,

M. Whit Walker,

Bradley A. Yoder

Publication year - 2017

Publication title -

jama pediatrics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.004

H-Index - 183

eISSN - 2168-6211

pISSN - 2168-6203

DOI - 10.1001/jamapediatrics.2017.2618

Subject(s) - bronchopulmonary dysplasia , medicine , pediatrics , birth weight , gestation , placebo , neonatal intensive care unit , nitric oxide , low birth weight , gestational age , anesthesia , pregnancy , genetics , alternative medicine , pathology , biology

Bronchopulmonary dysplasia (BPD) occurs in approximately 40% of infants born at younger than 30 weeks' gestation and is associated with adverse pulmonary and neurodevelopmental outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research